EdgarLookup

Zenas BioPharma, Inc. — All Filings

153 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-Q 3 4 4/A 424B4 424B5 424B7 8-A12B 8-K ARS CERT CORRESP D DEF 14A DEFA14A DRS DRS/A DRSLTR EFFECT FWP S-1 S-1/A S-1MEF S-3ASR S-8 SC 13D SC 13G SCHEDULE 13D SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
4 OWNERSHIP DOCUMENT 0001104659-25-058935 Jun 12, 2025 Jun 10, 2025
4 OWNERSHIP DOCUMENT 0001104659-25-058933 Jun 12, 2025 Jun 10, 2025
4 OWNERSHIP DOCUMENT 0001104659-25-058930 Jun 12, 2025 Jun 10, 2025
4 OWNERSHIP DOCUMENT 0001104659-25-058927 Jun 12, 2025 Jun 10, 2025
4 OWNERSHIP DOCUMENT 0001104659-25-058924 Jun 12, 2025 Jun 10, 2025
4 OWNERSHIP DOCUMENT 0001104659-25-058922 Jun 12, 2025 Jun 10, 2025
4 OWNERSHIP DOCUMENT 0001104659-25-058918 Jun 12, 2025 Jun 10, 2025
4 OWNERSHIP DOCUMENT 0001104659-25-058914 Jun 12, 2025 Jun 10, 2025
8-K FORM 8-K 0001104659-25-058892 Jun 12, 2025 Jun 10, 2025
SCHEDULE 13D 0001104659-25-057322 Jun 6, 2025
8-K FORM 8-K 0001104659-25-056215 Jun 4, 2025
10-Q 10-Q 0001558370-25-007803 May 15, 2025 Mar 31, 2025
8-K FORM 8-K 0001104659-25-048948 May 15, 2025
SCHEDULE 13G/A 0000315066-25-001413 May 12, 2025
4/A OWNERSHIP DOCUMENT 0001104659-25-039771 Apr 28, 2025 Feb 7, 2025
ARS ARS 0001104659-25-039770 Apr 28, 2025 Dec 31, 2024
DEFA14A DEFA14A 0001104659-25-039768 Apr 28, 2025
DEF 14A DEF 14A 0001104659-25-039765 Apr 28, 2025 Jun 10, 2025
4 OWNERSHIP DOCUMENT 0001104659-25-035996 Apr 17, 2025 Apr 15, 2025
SCHEDULE 13G 0000950170-25-048850 Apr 1, 2025
3 OWNERSHIP DOCUMENT 0001104659-25-026630 Mar 21, 2025 Mar 17, 2025
S-8 FORM S-8 0001104659-25-022386 Mar 11, 2025
10-K 10-K 0001558370-25-002631 Mar 11, 2025 Dec 31, 2024
4 OWNERSHIP DOCUMENT 0001104659-25-015145 Feb 19, 2025 Feb 18, 2025
4 OWNERSHIP DOCUMENT 0001104659-25-011505 Feb 11, 2025 Feb 7, 2025
8-K FORM 8-K 0001104659-25-009368 Feb 5, 2025
4 OWNERSHIP DOCUMENT 0001104659-24-129778 Dec 18, 2024 Dec 16, 2024
4 OWNERSHIP DOCUMENT 0001104659-24-129776 Dec 18, 2024 Dec 16, 2024
4 OWNERSHIP DOCUMENT 0001104659-24-125677 Dec 4, 2024 Dec 3, 2024
8-K FORM 8-K 0001104659-24-124616 Dec 2, 2024
4 OWNERSHIP DOCUMENT 0001104659-24-121081 Nov 20, 2024 Nov 18, 2024
SC 13G 0000315066-24-002940 Nov 12, 2024
10-Q 10-Q 0001558370-24-015162 Nov 12, 2024 Sep 30, 2024
8-K FORM 8-K 0001104659-24-116346 Nov 12, 2024
SC 13G NEA 18 VENTURE GROWTH EQUITY, L.P. -- ZENAS BIOPHARMA, INC. 13G 0001072613-24-000733 Sep 25, 2024
SC 13D SC 13D 0001193125-24-223899 Sep 23, 2024
SC 13D SC 13D 0001193125-24-223879 Sep 23, 2024
SC 13D SC 13D 0001104659-24-102046 Sep 23, 2024
4 OWNERSHIP DOCUMENT 0001104659-24-101773 Sep 20, 2024 Sep 18, 2024
4 OWNERSHIP DOCUMENT 0001104659-24-101030 Sep 18, 2024 Sep 16, 2024
4 0001415889-24-023609 Sep 18, 2024 Sep 16, 2024
4/A OWNERSHIP DOCUMENT 0001104659-24-100766 Sep 17, 2024 Sep 12, 2024
4/A OWNERSHIP DOCUMENT 0001104659-24-100765 Sep 17, 2024 Sep 12, 2024
4 0000919574-24-005530 Sep 17, 2024 Sep 13, 2024
4 OWNERSHIP DOCUMENT 0001104659-24-100339 Sep 16, 2024 Sep 12, 2024
4 OWNERSHIP DOCUMENT 0001104659-24-100338 Sep 16, 2024 Sep 12, 2024
4 OWNERSHIP DOCUMENT 0001104659-24-100337 Sep 16, 2024 Sep 12, 2024
4 OWNERSHIP DOCUMENT 0001104659-24-100335 Sep 16, 2024 Sep 12, 2024
4 OWNERSHIP DOCUMENT 0001104659-24-100333 Sep 16, 2024 Sep 12, 2024
4 OWNERSHIP DOCUMENT 0001104659-24-100332 Sep 16, 2024 Sep 12, 2024